The U.S. Food and Drug Administration (FDA) announced it will not clarify laws prohibiting the import of drugs from abroad, despite increasing evidence of alternative funding programs importing medications. These programs assist patients whose health plans do not cover expensive drugs.
Reports indicate that the U.S. Food and Drug Administration (FDA) intends to permit the production of 14 peptides that were previously banned due to safety concerns. This decision comes amid increasing calls for the use of these substances in medical treatments.
A raw dairy farm in the United States has announced a recall of several cheese products amid investigations by the FDA regarding an E. coli outbreak. This action follows reports of potential illnesses linked to these products.
The U.S. Food and Drug Administration (FDA) has granted fast approval for a new drug from Eli Lilly aimed at addressing obesity. This decision comes as many countries face rising obesity rates among their populations, raising significant public health concerns.
The U.S. Food and Drug Administration has announced a recall of chocolate products after discovering they contained undisclosed pharmaceutical ingredients. These substances pose a public health risk, especially for individuals taking heart medications.
Pfizer announced it will request approval from the FDA for a Lyme disease vaccine, despite not meeting statistical goals in clinical trials. Lyme disease, transmitted by ticks, poses serious health risks, necessitating further research and analysis.